Overview
Dr. Ramdin is a board-certified and fellowship-trained cancer physician specializing in medical oncology and hematology. She attended the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, where she earned her medical degree. She completed her residency at Roger Williams Medical Center, and completed her fellowship in hematology/oncology at Rhode Island Hospital. Dr. Ramdin is certified by the American Board of Internal Medicine.
Dr. Ramdin is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, and Adenoid Cystic Carcinoma.
Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 North Academy Avenue, Danville, PA 17822
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
UPMC Gynecologic Oncology
John T. Comerci, MD, is a surgical oncologist, director of Gynecologic Oncology at UPMC Passavant Hospital, and associate professor at the University of Pittsburgh School of Medicine. His expertise is in robotic surgery and the diagnosis and management of diseases of the female reproductive organs, including ovarian, uterine, cervical, and vulvar cancers. His research interests include photodynamic therapy in the treatment of cervical and ovarian cancer. Dr. Comerci is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Testicular Yolk Sac Tumor, and Vulvectomy.
UPMC Gynecologic Oncology
Joshua Kesterson, MD, is a fellowship-trained gynecologic oncologist and medical director of the gynecologic oncology program at UPMC in Central Pa. He received his medical degree from the University of Missouri and completed his residency in obstetrics, gynecology and women’s health at the University of Louisville, followed by his fellowship in gynecologic oncology at Roswell Park Cancer Institute. He is board-certified in obstetrics and gynecology and gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Kesterson’s clinical interests include gynecologic oncology such as ovarian, cervical, and endometrial cancer, immunotherapy, and HPV, and his research interests include quality improvement, ovarian cancer, and endometrial carcinoma. He is a member of the Society for Gynecologic Oncologists, the Foundation for Women’s Cancer, and Alpha Omega Alpha Honor Society. Dr. Kesterson is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, and Sertoli-Leydig Cell Tumor.
PinnacleHealth Women's Cancer Center
Mark Miller, DO, specializes in gynecologic oncology and obstetrics and gynecology and practices at PinnacleHealth Women's Cancer Center. He is affiliated with UPMC Williamsport. He completed his residency at Philadelphia College of Osteopathic Medicine and medical degree at Lake Erie College of Osteopathic Medicine. Dr. Miller is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Malignant Mixed Mullerian Tumor, Sertoli-Leydig Cell Tumor, Endometrial Cancer, Knee Replacement, and Osteotomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Pancreatic CancerDr. Ramdin isDistinguished. Learn about Familial Pancreatic Cancer.
- Lung CancerDr. Ramdin isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Ramdin isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Adenoid Cystic CarcinomaDr. Ramdin isAdvanced. Learn about Adenoid Cystic Carcinoma.
- ALK-Positive Non-Small Cell Lung Cancer
- AngiosarcomaDr. Ramdin isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Ramdin isAdvanced. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Ramdin isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Colorectal CancerDr. Ramdin isAdvanced. Learn about Familial Colorectal Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Hepatic Porphyria (AHP)Dr. Ramdin isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Ramdin isExperienced. Learn about Acute Intermittent Porphyria.
- Acute Mountain SicknessDr. Ramdin isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation